Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED20/20 Biolabs Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2026 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q3 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q4 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
20/20 Biolabs Inc Earnings Date And Information
20/20 Biolabs Inc last posted its earnings results on Friday, August 14th, 2026. The company reported $-0.26 earnings per share for the quarter, missing analysts' consensus estimates of $-0.12 by $0.14. The company had revenue of 730.57 K for the quarter and had revenue of 2.05 M for the year. 20/20 Biolabs Inc has generated $-1 earnings per share over the last year ($-0.6 diluted earnings per share) and currently has a price-to-earnings ratio of -0.25. 20/20 Biolabs Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
20/20 Biolabs Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2026 | Q2 2026 | -$0.12 | -$0.26 | -0.14 | $636.00 K | $730.57 K |
| 05/20/2026 | Q1 2026 | -$0.10 | -$0.20 | -0.1 | $779.00 K | $353.38 K |
| 03/31/2026 | Q4 2025 | N/A | -$0.13 | N/A | N/A | $538.27 K |
| 09/30/2025 | Q3 2025 | N/A | -$0.17 | N/A | N/A | $417.98 K |
| 06/30/2025 | Q2 2025 | N/A | -$0.08 | N/A | N/A | $535.06 K |
| 03/31/2025 | Q1 2025 | N/A | -$0.07 | N/A | N/A | $553.82 K |
| 12/31/2024 | Q4 2024 | N/A | -$0.26 | N/A | N/A | $536.08 K |
| 09/30/2024 | Q3 2024 | N/A | -$0.39 | N/A | N/A | $361.01 K |
| 06/30/2024 | Q2 2024 | N/A | -$0.25 | N/A | N/A | $427.63 K |
| 03/31/2024 | Q1 2024 | N/A | -$0.25 | N/A | N/A | $427.63 K |
| 12/31/2023 | Q4 2023 | N/A | -$0.28 | N/A | N/A | $334.49 K |
| 09/30/2023 | Q3 2023 | N/A | -$0.28 | N/A | N/A | $334.49 K |
| 06/30/2023 | Q2 2023 | N/A | -$0.36 | N/A | N/A | $335.94 K |
| 03/31/2023 | Q1 2023 | N/A | -$0.42 | N/A | N/A | $419.38 K |
| 12/31/2022 | Q4 2022 | N/A | -$0.13 | N/A | N/A | $983.76 K |
| 09/30/2022 | Q3 2022 | N/A | -$0.13 | N/A | N/A | $983.76 K |
| 06/30/2022 | Q2 2022 | N/A | $0.30 | N/A | N/A | $4.13 M |
| 03/31/2022 | Q1 2022 | N/A | $0.41 | N/A | N/A | $4.96 M |
| 12/31/2021 | Q4 2021 | N/A | $0.30 | N/A | N/A | $3.91 M |
| 09/30/2021 | Q3 2021 | N/A | $0.30 | N/A | N/A | $3.91 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
20/20 Biolabs Inc Earnings: FAQ's
The conference call for 20/20 Biolabs Inc's latest earnings report can be listened to online.
The conference call transcript for 20/20 Biolabs Inc's latest earnings report can be read online.
20/20 Biolabs Inc (:AIDX) has a recorded annual revenue of $2.05 M.
20/20 Biolabs Inc (:AIDX) has a recorded net income of $-3,738,821.20/20 Biolabs Inc has generated $-0.6 earnings per share over the last four quarters.
20/20 Biolabs Inc (:AIDX) has a price-to-earnings ratio of -0.25 and price/earnings-to-growth ratio is 0.01.